ANTX
AN2 Therapeutics, Inc.
Company overview
- Market capitalization
- $189.06M
- Employees
- 21
- Latest publication
- 2026-09-29
About AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics. The company's initial candidate includes epetraborole, which is phase 3 clinical trial as a once-daily oral treatment for patients with non-tuberculous mycobacterial lung disease, as well as studying for the treatment of acute melioidosis. It also develops AN2-502998 (AN15368), an investigational, boron-based small molecule in development for the treatment of chronic Chagas disease that is in preclinical trials; and has various research programs targeting the development of novel compounds in oncology and infectious disease based on its boron chemistry platform. It has a license agreement with Anacor Pharmaceuticals, Inc. to use, develop, manufacture, commercialize compounds and products, including epetraborole for the treatment, diagnosis, or prevention of various human diseases; and Brii Biosciences Limited to research, develop, manufacture, and commercialize compounds and products comprising epetraborole in China, Hong Kong, Taiwan, and Macau for the diagnosis, treatment, and prevention of human diseases; and GSK plc for the development of new therapies for TB. AN2 Therapeutics, Inc. was incorporated in 2017 and is headquartered in Menlo Park, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Research Development | 6,743,000USD | 6,879,000USD | 7,000,000USD | 3,200,000USD | 7,690,000USD | 5,397,000USD | 8,287,000USD | 12,149,000USD |
| Selling General Administrative | 3,808,000USD | 2,437,000USD | 3,040,000USD | 4,016,000USD | 3,847,000USD | 3,210,000USD | 3,484,000USD | 3,731,000USD |
| Total Operating Expenses | 10,551,000USD | 9,316,000USD | 10,040,000USD | 7,216,000USD | 11,537,000USD | 8,598,000USD | 14,014,000USD | 15,880,000USD |
| Operating Income | -10,551,000USD | -9,316,000USD | -10,040,000USD | -7,216,000USD | -11,537,000USD | -8,598,000USD | -14,014,000USD | -15,880,000USD |
| Interest Income | 523,000USD | 605,000USD | 687,000USD | 754,000USD | 888,000USD | — | 1,267,000USD | 1,445,000USD |
| Net Interest Income | 523,000USD | 605,000USD | 687,000USD | 754,000USD | 888,000USD | — | 1,267,000USD | 1,445,000USD |
| Income Before Tax | -10,028,000USD | -8,710,000USD | -9,353,000USD | -6,462,000USD | -10,649,000USD | -7,522,000USD | -12,747,000USD | -14,435,000USD |
| Net Income | -10,028,000USD | -8,710,000USD | -9,353,000USD | -6,462,000USD | -10,649,000USD | -7,522,000USD | -12,747,000USD | -14,435,000USD |
| Net Income From Continuing Ops | -10,028,000USD | -8,710,000USD | -9,353,000USD | -6,462,000USD | -10,649,000USD | -7,522,000USD | -12,747,000USD | -14,435,000USD |
| Ebitda | -10,028,000USD | -10,003,000USD | -9,353,000USD | -7,216,000USD | -11,537,000USD | -7,522,000USD | -11,771,000USD | 9,528,000USD |
| Total Other Income Expense Net | 523,000USD | 606,000USD | 687,000USD | 754,000USD | 888,000USD | 1,076,000USD | 1,267,000USD | 1,445,000USD |
| Ebit | — | — | — | -7,216,000USD | -11,537,000USD | -17,214,000USD | -14,014,000USD | -15,880,000USD |
| Depreciation And Amortization | — | — | — | — | — | 8,607,000USD | 2,243,000USD | 25,408,000USD |
| Unclassified Operating Expenses | — | — | — | — | — | — | 2,243,000USD | — |
| Income Tax Expense | — | — | — | — | — | — | — | -15,880,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | — |
| Research Development | 24,769,000USD | 40,488,000USD | 54,871,000USD | 29,511,000USD | 16,906,000USD | 6,019,000USD | 29,334,000USD |
| Selling General Administrative | 13,340,000USD | 14,066,000USD | 14,764,000USD | 12,751,000USD | 4,668,000USD | 1,265,000USD | 1,734,000USD |
| Total Operating Expenses | 38,109,000USD | 54,554,000USD | 69,635,000USD | 42,262,000USD | 21,574,000USD | 7,284,000USD | 31,068,000USD |
| Operating Income | -38,109,000USD | -54,554,000USD | -69,635,000USD | -42,262,000USD | -21,574,000USD | -7,284,000USD | -31,068,000USD |
| Interest Income | 2,934,000USD | 5,467,000USD | 4,860,000USD | 1,351,000USD | 69,000USD | 3,000USD | — |
| Net Interest Income | 2,934,000USD | 5,467,000USD | 4,860,000USD | 1,351,000USD | 69,000USD | 3,000USD | — |
| Income Before Tax | -35,174,000USD | -51,321,000USD | -64,732,000USD | -40,956,000USD | -21,543,000USD | -13,603,000USD | -33,810,000USD |
| Net Income | -35,174,000USD | -51,321,000USD | -64,732,000USD | -41,470,000USD | -21,474,000USD | -13,600,000USD | -33,810,000USD |
| Net Income From Continuing Ops | -35,174,000USD | -51,321,000USD | -59,676,000USD | -40,956,000USD | -21,543,000USD | -13,603,000USD | — |
| Ebitda | -38,109,000USD | 3,233,000USD | 4,903,000USD | -43,468,000USD | -21,474,000USD | -7,284,000USD | -5,178,000USD |
| Total Other Income Expense Net | 2,935,000USD | 3,233,000USD | 4,903,000USD | 1,306,000USD | 31,000USD | -6,319,000USD | -2,742,000USD |
| Ebit | — | -51,321,000USD | -64,732,000USD | -42,262,000USD | -21,574,000USD | -7,284,000USD | -36,246,000USD |
| Depreciation And Amortization | — | 54,554,000USD | 69,635,000USD | -1,206,000USD | 100,000USD | 7,284USD | 31,068,000USD |
| Income Tax Expense | — | — | -69,635USD | 514,000USD | -69,000USD | -3,000USD | -31,068USD |
| Cost Of Revenue | — | — | — | 77,000USD | — | — | — |
| Gross Profit | — | — | — | -77,000USD | — | — | — |
| Interest Expense | — | — | — | 514,000USD | 69,000USD | 3,000USD | 0USD |
| Net Income Applicable To Common Shares | — | — | — | -42,776,000USD | -28,058,000USD | -14,584,000USD | -34,404,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | 287,266USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 81,676,000USD | 87,491,000USD | 61,950,000USD | 67,235,000USD | 75,825,000USD | 81,343,000USD | 92,087,000USD | 97,689,000USD |
| Cash And Equivalents | 44,318,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 79,991,000USD | 87,491,000USD | 59,937,000USD | 64,016,000USD | 67,524,000USD | 69,559,000USD | 86,262,000USD | 97,689,000USD |
| Other Current Assets | 1,604,000USD | 2,203,000USD | 1,036,000USD | 1,695,000USD | 1,908,000USD | 2,499,000USD | 2,344,000USD | 3,263,000USD |
| Other Non Current Assets | 216,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 5,755,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 5,585,000USD | 5,562,000USD | 8,720,000USD | 2,226,000USD | 2,113,000USD | 8,014,000USD | 10,238,000USD | 10,017,000USD |
| Other Current Liabilities | 776,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 170,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 75,921,000USD | 81,759,000USD | 53,060,000USD | 60,377,000USD | 68,842,000USD | 73,329,000USD | 81,849,000USD | 87,672,000USD |
| Total Equity Including Noncontrolling Interest | 75,921,000USD | — | — | — | — | — | — | — |
| Accounts Payable | 1,967,000USD | 2,615,000USD | 3,021,000USD | 2,226,000USD | 2,113,000USD | 3,073,000USD | 3,317,000USD | 1,711,000USD |
| Retained Earnings | -259,163,000USD | -250,978,000USD | -240,950,000USD | -232,240,000USD | -222,887,000USD | -216,425,000USD | -205,776,000USD | -198,254,000USD |
| Accumulated Other Comprehensive Income | -23,000USD | -5,000USD | 57,000USD | 64,000USD | 25,000USD | 48,000USD | 31,000USD | 112,000USD |
| Total Liab | — | 5,732,000USD | 8,890,000USD | 6,858,000USD | 6,983,000USD | 8,014,000USD | 10,238,000USD | 10,017,000USD |
| Other Current Liab | — | 2,947,000USD | 5,699,000USD | 183,000USD | 717,000USD | 4,941,000USD | 6,921,000USD | 8,306,000USD |
| Capital Stock | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cash | — | 53,487,000USD | 19,941,000USD | 18,003,000USD | 18,220,000USD | 19,985,000USD | 21,351,000USD | 33,504,000USD |
| Cash And Short Term Investments | — | 85,288,000USD | 58,001,000USD | 61,921,000USD | 62,916,000USD | 67,060,000USD | 83,618,000USD | 93,426,000USD |
| Net Debt | — | -53,487,000USD | -19,941,000USD | -18,003,000USD | -18,220,000USD | -19,985,000USD | -21,351,000USD | -33,504,000USD |
| Long Term Investments | — | 0USD | 2,013,000USD | 3,219,000USD | 8,301,000USD | 11,480,000USD | 5,021,000USD | 0USD |
| Short Term Investments | — | 31,801,000USD | 38,060,000USD | 43,918,000USD | 44,696,000USD | 47,075,000USD | 62,267,000USD | 59,922,000USD |
| Common Stock Shares Outstanding | — | 34,059,876shares | 30,215,747shares | 30,276,230shares | 30,172,328shares | 30,054,000shares | 29,883,000shares | 29,841,000shares |
| Non Current Assets Total | — | 0USD | 2,013,000USD | 3,219,000USD | 8,301,000USD | 11,784,000USD | 5,825,000USD | 0USD |
| Non Current Liabilities Total | — | 170,000USD | 170,000USD | 4,632,000USD | 4,870,000USD | 0USD | 0USD | 0USD |
| Non Current Liabilities Other | — | 170,000USD | 170,000USD | — | — | — | — | — |
| Net Working Capital | — | 81,929,000USD | 51,217,000USD | 57,158,000USD | 60,541,000USD | 61,545,000USD | 76,024,000USD | 87,672,000USD |
| Unclassified Equity | — | 332,742,000USD | 293,953,000USD | 292,553,000USD | 291,704,000USD | 289,706,000USD | 287,594,000USD | 285,814,000USD |
| Net Receivables | — | — | 900,000USD | 400,000USD | 2,700,000USD | 300,000USD | 300,000USD | 1,000,000USD |
| Unclassified Non Current Liabilities | — | — | — | 4,632,000USD | 4,870,000USD | — | — | — |
| Non Currrent Assets Other | — | — | — | — | — | 304,000USD | 804,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Assets | 61,950,000USD | 92,087,000USD | 138,744,000USD | 102,560,000USD | 65,316,000USD | 4,234,000USD | 5,700,000USD |
| Other Current Assets | 1,036,000USD | 2,344,000USD | 1,812,000USD | 2,562,000USD | 1,551,000USD | 164,000USD | 102,000USD |
| Total Liab | 8,890,000USD | 10,238,000USD | 14,043,000USD | 7,188,000USD | 3,408,000USD | 1,483,000USD | 887,000USD |
| Total Stockholder Equity | 53,060,000USD | 81,849,000USD | 124,701,000USD | 95,372,000USD | 61,908,000USD | 2,751,000USD | 4,813,000USD |
| Other Current Liab | 5,699,000USD | 6,921,000USD | 11,367,000USD | 5,011,000USD | 2,332,000USD | 1,327,000USD | 108,000USD |
| Capital Stock | 0USD | 0USD | 0USD | 0USD | 109,319,000USD | 0USD | — |
| Retained Earnings | -240,950,000USD | -205,776,000USD | -154,455,000USD | -89,723,000USD | -47,384,000USD | -20,319,000USD | -5,801,000USD |
| Cash | 19,941,000USD | 21,351,000USD | 15,647,000USD | 27,219,000USD | 12,097,000USD | 4,070,000USD | 5,598,000USD |
| Cash And Short Term Investments | 58,001,000USD | 83,618,000USD | 107,295,000USD | 96,059,000USD | 58,555,000USD | 4,070,000USD | 5,598,000USD |
| Total Current Assets | 59,937,000USD | 86,262,000USD | 110,507,000USD | 98,621,000USD | 60,106,000USD | 4,234,000USD | 5,700,000USD |
| Total Current Liabilities | 8,720,000USD | 10,238,000USD | 14,043,000USD | 7,186,000USD | 3,395,000USD | 1,459,000USD | 159,000USD |
| Net Debt | -19,941,000USD | -21,351,000USD | -15,647,000USD | -27,166,000USD | -12,097,000USD | -4,070,000USD | -4,870,000USD |
| Long Term Investments | 2,013,000USD | 5,021,000USD | 27,194,000USD | 3,219,000USD | 3,486,000USD | 0USD | — |
| Short Term Investments | 38,060,000USD | 62,267,000USD | 91,648,000USD | 68,840,000USD | 46,458,000USD | 0USD | — |
| Net Receivables | 900,000USD | 300,000USD | 1,400,000USD | — | — | — | — |
| Accounts Payable | 3,021,000USD | 3,317,000USD | 2,676,000USD | 2,122,000USD | 1,063,000USD | 132,000USD | 51,000USD |
| Accumulated Other Comprehensive Income | 57,000USD | 31,000USD | 275,000USD | -374,000USD | -27,000USD | — | — |
| Common Stock Shares Outstanding | 30,215,747shares | 29,828,000shares | 23,600,000shares | 15,340,000shares | 18,740,000shares | 18,740,000shares | 18,740,000shares |
| Non Current Assets Total | 2,013,000USD | 5,825,000USD | 28,237,000USD | 3,939,000USD | 5,210,000USD | 0USD | — |
| Non Current Liabilities Total | 170,000USD | 0USD | 0USD | 2,000USD | 13,000USD | 24,000USD | 728,000USD |
| Non Current Liabilities Other | 170,000USD | — | — | 2,000USD | — | — | — |
| Net Working Capital | 51,217,000USD | 76,024,000USD | 96,464,000USD | 91,435,000USD | 56,711,000USD | 2,775,000USD | — |
| Unclassified Equity | 293,953,000USD | 287,594,000USD | 278,881,000USD | 185,469,000USD | — | 23,070,000USD | 10,614,000USD |
| Non Currrent Assets Other | — | 804,000USD | 1,043,000USD | 667,000USD | 1,724,000USD | — | — |
| Other Assets | — | — | 1USD | 720,000USD | 1,724,000USD | — | — |
| Short Term Debt | — | — | — | 53,000USD | — | — | — |
| Short Long Term Debt Total | — | — | — | 53,000USD | — | — | 728,000USD |
| Property Plant Equipment Net | — | — | — | 53,000USD | — | — | — |
| Net Tangible Assets | — | — | — | 95,372,000USD | -47,411,000USD | -20,319,000USD | -5,801,000USD |
| Deferred Long Term Liab | — | — | — | — | 1,724,000USD | — | — |
| Other Liab | — | — | — | — | 13,000USD | 24,000USD | — |
| Unclassified Non Current Assets | — | — | — | — | -1,724,000USD | — | — |
| Unclassified Non Current Liabilities | — | — | — | — | -1,724,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Stock Based Compensation | 2,432,000USD |
| Change To Liabilities | -2,244,000USD |
| Change In Working Capital | -951,000USD |
| Operating Cash Flow | -19,071,000USD |
| Net Investments | 4,630,000USD |
| Investing Cash Flow | 4,630,000USD |
| Common Stock Issuance | 39,000USD |
| Unclassified Financing Cash Flow | 38,779,000USD |
| Financing Cash Flow | 38,818,000USD |
| Change In Cash | 24,377,000USD |
| End Cash Flow | 44,318,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -10,028,000USD | -8,710,000USD | -9,353,000USD | -6,462,000USD | -10,649,000USD | -7,522,000USD | -12,747,000USD | -14,435,000USD |
| Stock Based Compensation | 1,460,000USD | 1,400,000USD | 801,000USD | 1,998,000USD | 2,047,000USD | 1,780,000USD | 1,902,000USD | 2,271,000USD |
| Other Non Cash Items | 1,379,000USD | -117,000USD | -211,000USD | -299,000USD | -443,000USD | -567,000USD | -731,000USD | -890,000USD |
| Change In Working Capital | -3,424,000USD | 2,191,000USD | 2,388,000USD | -2,836,000USD | -1,579,000USD | 1,036,000USD | -431,000USD | -1,330,000USD |
| Total Cash From Operating Activities | -12,073,000USD | -5,236,000USD | -6,375,000USD | -7,599,000USD | -10,624,000USD | -5,273,000USD | -12,007,000USD | -14,384,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -12,073,000USD | -5,236,000USD | -6,375,000USD | -7,599,000USD | -10,624,000USD | -5,273,000USD | -12,007,000USD | -14,384,000USD |
| Investments | 8,290,000USD | 7,174,000USD | 6,110,000USD | 5,834,000USD | 9,193,000USD | -6,880,000USD | 18,719,000USD | 16,460,000USD |
| Total Cashflows From Investing Activities | 8,289,999USD | 7,174,000USD | 6,110,000USD | 5,834,000USD | 9,193,000USD | -6,880,000USD | 18,719,000USD | 16,460,000USD |
| Total Cash From Financing Activities | 37,329,000USD | 0USD | 48,000USD | 0USD | 65,000USD | 0USD | 23,000USD | 0USD |
| Issuance Of Capital Stock | 37,266,000USD | — | — | — | 0USD | 0USD | 0USD | — |
| Change In Cash | 33,546,000USD | 1,938,000USD | -217,000USD | -1,765,000USD | -1,366,000USD | -12,153,000USD | 6,735,000USD | 2,076,000USD |
| Begin Period Cash Flow | 19,941,000USD | 18,003,000USD | 18,220,000USD | 19,985,000USD | 21,351,000USD | 33,504,000USD | 26,769,000USD | 24,693,000USD |
| End Period Cash Flow | 53,487,000USD | 19,941,000USD | 18,003,000USD | 18,220,000USD | 19,985,000USD | 21,351,000USD | 33,504,000USD | 26,769,000USD |
| Other Cashflows From Financing Activities | 37,329,000USD | 113,000USD | 48,000USD | — | 65,000USD | — | 23,000USD | 16,460,000USD |
| Unclassified Operating Cash Flow | -1,460,000USD | — | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | -37,266,000USD | — | — | — | — | — | — | -16,460,000USD |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | — | 16,460,000USD |
| Unclassified Investing Cash Flow | — | — | — | — | — | — | — | -16,460,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Net Income | -35,174,000USD | -51,321,000USD | -64,732,000USD | -40,956,000USD | -21,543,000USD | -13,603,000USD | -5,635,000USD |
| Stock Based Compensation | 6,246,000USD | 8,338,000USD | 8,412,000USD | 4,391,000USD | 974,000USD | 40,000USD | — |
| Other Non Cash Items | -1,070,000USD | -3,279,000USD | -2,802,000USD | 77,000USD | 53,000USD | 6,975,000USD | 3,159,000USD |
| Change In Working Capital | 164,000USD | -2,995,000USD | 5,834,000USD | 3,718,000USD | 32,000USD | 1,224,000USD | -10,000USD |
| Total Cash From Operating Activities | -29,834,000USD | -49,257,000USD | -53,288,000USD | -33,462,000USD | -20,484,000USD | -5,364,000USD | -2,486,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -29,834,000USD | -49,257,000USD | -53,288,000USD | -33,462,000USD | -20,484,000USD | -5,364,000USD | -2,486,000USD |
| Investments | 28,311,000USD | 54,589,000USD | -37,643,000USD | -21,771,000USD | -50,024,000USD | -50,024,000USD | -50,024,000USD |
| Total Cashflows From Investing Activities | 28,311,000USD | 54,589,000USD | -43,278,000USD | -21,771,000USD | -50,024,000USD | -50,024,000USD | -50,024,000USD |
| Total Cash From Financing Activities | 113,000USD | 372,000USD | 84,994,000USD | 70,355,000USD | 78,535,000USD | 3,836,000USD | 8,084,000USD |
| Change In Cash | -1,410,000USD | 5,704,000USD | -11,572,000USD | 15,122,000USD | 8,027,000USD | -1,528,000USD | 5,598,000USD |
| Begin Period Cash Flow | 21,351,000USD | 15,647,000USD | 27,219,000USD | 12,097,000USD | 4,070,000USD | 5,598,000USD | — |
| End Period Cash Flow | 19,941,000USD | 21,351,000USD | 15,647,000USD | 27,219,000USD | 12,097,000USD | 4,070,000USD | 5,598,000USD |
| Other Cashflows From Financing Activities | 113,000USD | 372,000USD | 465,000USD | 1,809,000USD | 78,535,000USD | 3,836,000USD | 8,084,000USD |
| Issuance Of Capital Stock | — | 0USD | 84,850,000USD | 70,366,000USD | 79,734,000USD | 3,772,000USD | — |
| Unclassified Investing Cash Flow | — | — | -5,635,000USD | — | — | — | — |
| Depreciation | — | — | — | -692,000USD | — | — | — |
| Change To Liabilities | — | — | — | 0USD | 417,000USD | 81,000USD | -96,000USD |
| Dividends Paid | — | — | — | -1,820,000USD | — | — | — |
| Sale Purchase Of Stock | — | — | — | -11,000USD | — | — | — |
| Other Cashflows From Investing Activities | — | — | — | -21,771USD | -50,024USD | — | — |
| Unclassified Financing Cash Flow | — | — | — | 70,377,000USD | -79,734,000USD | -3,772,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.